Health Care: Drugs

AMAG Pharmaceuticals Inc (AMAG: NASDAQ)

$19.76 -0.4 | -1.98%
07/30/14 - 11:29 AM ET
Company Profile
Price and Volume
Recent Price 20.16
52 Week High 28.42
52 Week Low 16.49
Avg. Daily Vol. (Mil) 0.36
Beta (3 year) 0.59
Share Related Items
Mkt Cap (Mil) 441.81
Shares Out (Mil) 21.92
Float (Mil) 15.54
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 11.00
Current Ratio 11.70
LT Debt/ Equity 0.85
Total Debt / Equity 0.85
Valuation Ratios
Price Earnings n.a.
Price/Sales 5.27
Price/Book 2.31
Price/Cash Flow -66.70
Per Share Data
Earnings -0.59
Sales 3.82
Book Value 8.72
Cash Flow -0.30
Business Summary
AMAG Pharmaceuticals Inc is a specialty pharmaceutical company that markets Feraheme Injection for Intravenous, or IV, use to treat iron deficiency anemia, or IDA, and MuGard Mucoadhesive Oral Wound Rinse for the management of oral mucositis.
General Information
1100 Winter Street
Waltham, MA 02421
www.amagpharma.com
Industry : Drugs
Sector: Health Care
Employees: 148
CEO: William K. Heiden
Short Interest
Current Month (Mil) 6.09
Previous Month (Mil) 5.95
Short Interest Ratio (Days) 18.10
Management Effectiveness
Return on Equity n.a.
Return on Assets -2.90
Return on Investments -3.60
Profitability
Gross Margin 93.20
EBIT Margin -13.50
Profit Margin -15.30

Portfolios with AMAG

Latest AMAG Headlines from TheStreet

More Financial News for AMAG

Press Releases for AMAG

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter